Nippon Shokubai Co.

Takayuki Murai has served as President and CEO since 2023, overseeing corporate strategy and capital allocation. The firm's investment decisions are made by the executive committee, which includes the CEO, CFO, and senior R&D executives. Capital expenditures are approved through a structured annual budget process tied to the firm's three-year business plan.

Nippon Shokubai is primarily a chemical manufacturer, producing acrylic acid, superabsorbent polymers (used in diapers and hygiene products), ethylene oxide derivatives, and industrial catalysts. Its revenue is roughly 60% from acrylic acid-based products and 40% from specialty chemicals and catalysts, per the firm's FY2024 annual report.

The firm does not function as a family office or asset manager. Its capital deployment is limited to internal capital expenditure, greenfield plants, and R&D projects. It holds minority stakes in some joint ventures (e.g., a SAP production JV in China with a local partner), but does not maintain a portfolio of external financial investments.

The firm operates a bio-based acrylic acid pilot plant in Japan, completed in 2022, and invests in catalyst R&D to reduce energy intensity. Its 'Green Chemistry' initiative aims to cut CO2 emissions by 30% by 2030 from 2019 levels, per the firm's sustainability report.

No. Nippon Shokubai is a publicly traded independent company listed on the Tokyo Stock Exchange (TSE: 4093). It is not controlled by a larger group; its largest shareholders include institutional investors and Japanese banks. The firm has no affiliation with the Nippon Shokubai name being used in other contexts.